Viewing Study NCT00045305


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-05-20 @ 11:53 AM
Study NCT ID: NCT00045305
Status: COMPLETED
Last Update Posted: 2023-06-28
First Post: 2002-09-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
Sponsor: Eastern Cooperative Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic myelomonocytic leukemia View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None refractory anemia View
None refractory anemia with excess blasts View
None refractory anemia with ringed sideroblasts View
None secondary myelodysplastic syndromes View
None atypical chronic myeloid leukemia, BCR-ABL1 negative View
None myelodysplastic/myeloproliferative neoplasm, unclassifiable View